title: GLP-1-based therapy for diabetes: what you do not know can hurt you.
authors.forename: Peter C
authors.initials: PC
authors.lastname: Butler
authors.forename: Sarah
authors.initials: S
authors.lastname: Dry
authors.forename: Robert
authors.initials: R
authors.lastname: Elashoff
mesh_terms: D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D009765:Obesity / Q000150:complications; D047495:PPAR gamma / Q000819:agonists; D010190:Pancreatic Neoplasms / Q000453:epidemiology; D018570:Risk Assessment; D012449:Safety
chemical_list: D007004:Hypoglycemic Agents; D047495:PPAR gamma; D052216:Glucagon-Like Peptide 1